Literature DB >> 7838320

A marked increase in intracellular Ca2+ concentration induced by acromelic acid in cultured rat spinal neurons.

T Ogata1, Y Nakamura, K Tsuji, T Shibata, K Kataoka, M Ishida, H Shinozaki.   

Abstract

Acromelic acid, a kainate derivative of natural origin, markedly increased intracellular Ca2+ concentration ([Ca2+]i) in cultured rat spinal neurons in a concentration dependent manner; the half effective concentration (EC50) was 1.3 microM. Acromelic acid was more potent in increasing [Ca2+]i than any other glutamate receptor agonists tested, and the rank order of the activity was as follows: acromelic acid > alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) > kainate > N-methyl-D-aspartate (NMDA) > L-glutamate. Acromelic acid did not increase the [Ca2+]i in a Ca(2+-)free medium. 2,3-Dihydroxy-9-nitro-7-sulfamoylbenzo(F)quinoxaline (NBQX) completely inhibited the [Ca2+]i increase induced by acromelic acid. These results suggest that the [Ca2+]i increase was not through Ca2+ mobilization from intracellular stores but due to Ca2+ influx mediated by the activation of non-NMDA receptors. Acromelic acid increased the [Ca2+]i in rat hippocampal neurons as well; however, the EC50 (6 microM) was considerably higher than that in spinal neurons. The marked increase of [Ca2+]i in cultured spinal neurons would explain, at least in part, the earlier findings that systemic administration of acromelic acid causes selective degeneration confined to lower spinal interneurons.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7838320     DOI: 10.1016/0028-3908(94)90146-5

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  1 in total

1.  Acute and late effects on induction of allodynia by acromelic acid, a mushroom poison related structurally to kainic acid.

Authors:  Toshiaki Minami; Shinji Matsumura; Mikio Nishizawa; Yasuyuki Sasaguri; Nobuyuki Hamanaka; Seiji Ito
Journal:  Br J Pharmacol       Date:  2004-05-24       Impact factor: 8.739

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.